New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
Research News Release
EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Eligibility GuidelinesEurekAlert! offers eligible public information officers paid access to a reliable news release distribution service.
Eligibility GuidelinesEurekAlert! is a service of the American Association for the Advancement of Science.
Combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to middle-income countries. Results from the study, which applied lessons learned from the hepatitis b vaccine platform technology, are published online today in Science Immunology.
Black and Latinx people intensely sought information on COVID-19 and engaged in public health measures such as mask-wearing and testing due to devastating experiences during the pandemic but are still skeptical about vaccines, according to a Rutgers study.
An observational study of more than 70,000 people in 302 UK hospitals finds that one in two people hospitalized with COVID-19 developed at least one complication. The new study, published in The Lancet, is the first to systematically assess a range of in-hospital complications, and their associations with age, sex and ethnicity, and their outcomes for the patients.
What The Study Did: In this observational study using data from the Veterans Health Administration for 2,344 U.S. veterans hospitalized with COVID-19, remdesivir treatment was associated with prolonged hospitalization but wasn't associated with improved survival.
What The Study Did: Among the few New York state public school districts providing full-time in-person elementary school instruction during the COVID-19 pandemic, most districts served predominately white students, rural/suburban students and children who were not disadvantaged (children who were not from a low-income family, were not English language learners, did not have homelessness, and did not have a disability).
What The Study Did: This community-engaged qualitative study describing Black and Latinx participants' experiences during the COVID-19 pandemic found that fear, illness and loss experienced during the pandemic motivated information seeking and mitigation behaviors, while vaccine skepticism was high, as was the demand for clearer information.
Patients who experience long COVID have reported more than 200 symptoms across 10 organ systems, in the largest international study of 'long-haulers' to date, led by UCL scientists together with a patient-led research collaborative.
Most of the heart and immunologic problems seen in children with multisystem inflammatory syndrome (MIS-C)--a condition linked to COVID--were gone within a few months, Columbia researchers have found.
Young children with pneumonia in Bangladesh frequently do not respond to common antibiotics, often resulting in death.
The lack of sequencing of SARS-CoV-2 variants by the U.S. and other countries is imperiling the global response to the COVID-19 pandemic, argues Dana Crawford of Case Western Reserve University in a new Viewpoint published July 15th in the journal PLOS Genetics.